| American Fork Vision Center Inc. | |
|
24 W Main St, American Fork, UT 84003-2318 | |
| (801) 756-7996 | |
| Not Available |
| Full Name | American Fork Vision Center Inc. |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 24 W Main St, American Fork, Utah |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548483019 | NPI | - | NPPES |
| 528111273016 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 152W00000X (Utah) | Primary |
| Provider Name | Paul A Paxman |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1124097068 PECOS PAC ID: 8921183518 Enrollment ID: I20080306000405 |
News Archive
A study involving more than 200,000 people worldwide has identified 29 DNA sequence variations in locations across the human genome that influence blood pressure.
For married couples in which one partner is HIV-positive and the other is HIV-negative, antiretroviral therapy (ART) does not reduce the risk of transmitting HIV to the uninfected partner, according to a study from China in the October issue of JAIDS: Journal of Acquired Immune Deficiency Syndromes.
A phase III clinical trial of an investigational Alzheimer's disease drug dimebon failed to show encouraging results dooming its future according to its commercial sponsors.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2011.
› Verified 7 days ago
| Provider Name | Marlyn Andrew Kyle |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1669964359 PECOS PAC ID: 0547697625 Enrollment ID: I20200302002040 |
News Archive
A study involving more than 200,000 people worldwide has identified 29 DNA sequence variations in locations across the human genome that influence blood pressure.
For married couples in which one partner is HIV-positive and the other is HIV-negative, antiretroviral therapy (ART) does not reduce the risk of transmitting HIV to the uninfected partner, according to a study from China in the October issue of JAIDS: Journal of Acquired Immune Deficiency Syndromes.
A phase III clinical trial of an investigational Alzheimer's disease drug dimebon failed to show encouraging results dooming its future according to its commercial sponsors.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2011.
› Verified 7 days ago
| Provider Name | Victoria Nielsen |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1295350247 PECOS PAC ID: 5991115669 Enrollment ID: I20201109001115 |
News Archive
A study involving more than 200,000 people worldwide has identified 29 DNA sequence variations in locations across the human genome that influence blood pressure.
For married couples in which one partner is HIV-positive and the other is HIV-negative, antiretroviral therapy (ART) does not reduce the risk of transmitting HIV to the uninfected partner, according to a study from China in the October issue of JAIDS: Journal of Acquired Immune Deficiency Syndromes.
A phase III clinical trial of an investigational Alzheimer's disease drug dimebon failed to show encouraging results dooming its future according to its commercial sponsors.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2011.
› Verified 7 days ago
| Provider Name | Daxton Aaron Hawks |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1821663675 PECOS PAC ID: 3678973492 Enrollment ID: I20210616002035 |
News Archive
A study involving more than 200,000 people worldwide has identified 29 DNA sequence variations in locations across the human genome that influence blood pressure.
For married couples in which one partner is HIV-positive and the other is HIV-negative, antiretroviral therapy (ART) does not reduce the risk of transmitting HIV to the uninfected partner, according to a study from China in the October issue of JAIDS: Journal of Acquired Immune Deficiency Syndromes.
A phase III clinical trial of an investigational Alzheimer's disease drug dimebon failed to show encouraging results dooming its future according to its commercial sponsors.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2011.
› Verified 7 days ago
| Provider Name | Katherine E Anderson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1487207296 PECOS PAC ID: 3375961931 Enrollment ID: I20231027001292 |
News Archive
A study involving more than 200,000 people worldwide has identified 29 DNA sequence variations in locations across the human genome that influence blood pressure.
For married couples in which one partner is HIV-positive and the other is HIV-negative, antiretroviral therapy (ART) does not reduce the risk of transmitting HIV to the uninfected partner, according to a study from China in the October issue of JAIDS: Journal of Acquired Immune Deficiency Syndromes.
A phase III clinical trial of an investigational Alzheimer's disease drug dimebon failed to show encouraging results dooming its future according to its commercial sponsors.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2011.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| American Fork Vision Center Inc. 24 W Main St, American Fork, UT 84003-2318 Ph: (801) 756-7996 | American Fork Vision Center Inc. 24 W Main St, American Fork, UT 84003-2318 Ph: (801) 756-7996 |
News Archive
A study involving more than 200,000 people worldwide has identified 29 DNA sequence variations in locations across the human genome that influence blood pressure.
For married couples in which one partner is HIV-positive and the other is HIV-negative, antiretroviral therapy (ART) does not reduce the risk of transmitting HIV to the uninfected partner, according to a study from China in the October issue of JAIDS: Journal of Acquired Immune Deficiency Syndromes.
A phase III clinical trial of an investigational Alzheimer's disease drug dimebon failed to show encouraging results dooming its future according to its commercial sponsors.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2011.
› Verified 7 days ago
Dr. Paul A. Paxman, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 24 W Main St, American Fork, UT 84003 Phone: 801-756-7996 | |
Clear View Vision Center Optometrist Medicare: Medicare Enrolled Practice Location: 60 S 200 E, American Fork, UT 84003 Phone: 801-756-4731 Fax: 801-756-5865 | |
Dr. Kenneth E Hooton, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 60 S 200 E, American Fork, UT 84003 Phone: 801-756-4731 Fax: 801-756-5865 | |
Edward R Nicholls, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 323 W State Rd Ste A, American Fork, UT 84003 Phone: 801-763-9898 Fax: 801-763-7217 | |
Tyler Meek, OD Optometrist Medicare: Medicare Enrolled Practice Location: 60 S 200 E, American Fork, UT 84003 Phone: 801-756-4731 | |
Dr. Marlyn Andrew Kyle, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 24 W Main St, American Fork, UT 84003 Phone: 801-756-7996 |